The Assessment of Patient Specific Instrumentation for Unicompartmental Knee Replacement

October 18, 2021 updated by: Oxford University Hospitals NHS Trust
Patient-specific instrumentation guides have previously been used to improving surgical accuracy and ease of implantation during Total Knee Replacement but have received less attention for implanting Unicompartmental Knee Replacement. The aim of this prospective study is to compare the accuracy of implantation and functional outcome of mobile bearing medial Unicompartmental Knee Replacement implanted with and without patient specific instrumentation by experienced knee surgeons.

Study Overview

Detailed Description

The aim of this prospective study is to compare the accuracy of implantation and functional outcome of mobile bearing medial Unicompartmental Knee Replacements implanted with and without patient specific instrumentation by experienced Unicompartmental Knee Replacement surgeons.

This single-centre parallel-design trial was conducted between March 2012 and March 2014 at the Nuffield Orthopaedic Centre, Oxford. Four expert knee surgeons performed all of the procedures in this study. Patients who were being placed on the waiting list for a medial Unicompartmental Knee Replacement, and met the entry criteria for the trial, were asked to see if they would be willing to receive further information about participation in the study. They were provided with a study information leaflet that they could read in their own time. A member of the research team subsequently contacted the patients in order to determine if they would agree to take part in the study and enrolled them onto the study.

Patients were randomized to either Patient Specific Instrumentation, or Conventional Instrumentation group. There were 23 patients (23 knees) in the Patient Specific Instrumentation group and 22 patients (22 knees) in the Conventional Instrumentation group. Randomization was performed using sealed opaque envelopes. Concealment from operating surgeons and patients was not possible owing to the surgeon needing to confirm the Patient Specific Instrumentation plans, and the patients undergoing pre-operative MRI scans. Patient Specific Instrumentation group patients underwent an MRI scan using the protocol outlined by the Patient Specific Instrumentation manufacturers to plan development of the Patient Specific Instrumentation guides. The preliminary plan indicating prosthesis size, positioning, alignment, and proposed bone resection levels was reviewed by the surgeons who accepted the default preoperative plans unless gross errors were present. The patient specific cutting blocks were then manufactured and sent for sterilization.

Operative Technique:

All patients received a mobile bearing medial Oxford unicompartmental knee replacement via a minimally invasive approach under general anaesthetic, and high thigh tourniquet. Intra-operatively, the bone cuts were made through the Patient Specific Instrumentation guides without the use of any intra or extra-medullary instrumentation on the femoral side but with a tibial extramedullary guide for some cases. The subsequent milling process and all soft tissue balancing was performed manually in the standard fashion.

Post-operatively, the need to have a blood transfusion, and the change haemoglobin levels were also recorded. Oxygen saturation levels over the first 24 hours post surgery were also recorded. Screened anteroposterior and lateral post-operative radiographs were performed prior to discharge. Patients attended the physiotherapy ward discharge clinic at six weeks. A further clinical review was performed at 12 months at which point Oxford Knee Scores were recorded.

The primary outcome measure was radiological assessment of component positioning. (See Outcome measures section for more detail)

Target sample size:

The sample size was calculated from a previous study that used similar radiological assessments to compare unicompartmental knee replacements performed using conventional instrumentation, with those performed using computer navigation. In this study, the standard deviation of the tibia varus/valgus angle for the control group was 3.6°. Assuming a minimum clinically important difference of 3°, the standard mean difference would be 0.8. Hence with a power of 0.8 and significance level of 0.05, a total sample size of 44 patients (22 in each group) was required.

Study Type

Interventional

Enrollment (Actual)

45

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Both cruciate ligaments functionally intact
  • Full thickness cartilage in the lateral compartment
  • Correctable intra-articular varus deformity
  • Full thickness cartilage loss in the medial compartment

Exclusion Criteria:

  • Contra-indication for MRI
  • All forms of inflammatory arthritis

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Patient Specific Instrumentation
Patients undergoing unicompartmental knee replacement with the additional aid of patient specific instrumentation.
Patients will undergo a medial unicompartmental knee replacement. This knee replacement is implanted using patient specific cutting guides that have been produced based on the patient's individual anatomy (using plans from pre-operative MRI scans of the patient's knee).
Active Comparator: Conventional Instrumentation
Patients undergoing unicompartmental knee replacement using standard instrumentation.
Patients will undergo a medial unicompartmental knee replacement using standard conventional instruments.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Radiological Assessment of Component Positioning
Time Frame: Within a weeks after surgery
Radiological assessment of component positioning and alignment based on post-operative knee radiographs.
Within a weeks after surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Assessment of Functional Outcome
Time Frame: One year after surgery

Use of the patient reported outcome tool (Oxford Knee Score) to determine functional outcome at one year following surgery.

Total score is 48. Minimum score 0 and Maximum score 48 with higher score indicating better function.

Scores on a scale

One year after surgery

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Post-operative Change in Haemoglobin Between Baseline Baseline and 48 Hours After Surgery
Time Frame: Within the first 48 hours after surgery
Change in haemoglobin levels between baseline and 48 hours after surgery will be determined
Within the first 48 hours after surgery
Number of Participants With The Need for Blood Transfusion Following Surgery
Time Frame: Within the first 48 hours after surgery
Number of Participants with The Need for Blood Transfusion within 48 hours of Surgery
Within the first 48 hours after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Andrew Price, FRCS PhD, Nuffield Department of Orthopaedics, Rheumatology & Musculoskeletal Sciences, University of Oxford

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2012

Primary Completion (Actual)

February 1, 2013

Study Completion (Actual)

March 1, 2014

Study Registration Dates

First Submitted

April 15, 2016

First Submitted That Met QC Criteria

April 21, 2016

First Posted (Estimate)

April 22, 2016

Study Record Updates

Last Update Posted (Actual)

November 16, 2021

Last Update Submitted That Met QC Criteria

October 18, 2021

Last Verified

April 1, 2016

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Plan to publish in high impact peer reviewed orthopaedic journal

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Knee Arthritis

Clinical Trials on Patient Specific Instrumentation

Subscribe